Page breadcrumb nav

VAERS Report 2156833

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fn5254


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-10
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

rib pain/this time is more intense and constant; rib pain/this time is more intense and constant; covid-19 vaccine astrazeneca/comrinaty; covid-19 vaccine astrazeneca/comrinaty; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202181801309620-j1dht. other case identifier(s): gb-mhra-adr 26622004. a 45 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 10feb2022 (lot number: fn5254) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "radiotherapy" (unspecified if ongoing); "cancer", start date: aug2019 (unspecified if ongoing), notes: with chemotherapy and radiotherapy; "neoplasm" (unspecified if ongoing), notes: recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy); "chemotherapy" (unspecified if ongoing); "breast cancer" (unspecified if ongoing). patient last menstrual period was on 10feb2022. patient has not had symptoms associated with covid-19. patient is not currently breastfeeding. concomitant medication(s) included: tamoxifen [tamoxifen citrate] taken for breast cancer, start date: 01may2019 (ongoing). vaccination history included: covid-19 vaccine astrazeneca (dose 1), administration date: 06may2021, for covid-19 immunisation, reaction(s): "rib pain"; covid-19 vaccine astrazeneca (dose 2), administration date: 27jul2021, for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant) all with onset 10feb2022, outcome "unknown" and all described as "covid-19 vaccine astrazeneca/comrinaty"; musculoskeletal chest pain (medically significant), condition aggravated (medically significant) all with onset 15feb2022, outcome "not recovered" and all described as "rib pain/this time is more intense and constant". the event "rib pain/this time is more intense and constant" was evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17feb2022) negative, notes: no - negative covid-19 test; scan: (unspecified date) did not detect any issues. clinical course: the patient further reported intense, constant rib pain on same side as vaccine. spoke to physician (gp) who was investigating further. similar pain was felt after dose 1 of covid vaccine and had only just begun to disappear. this time is more intense and constant. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. the report does not relate to possible inflammation of the heart (myocarditis or pericarditis). scan carried out after dose 1 but did not detect any issues. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test date: 20220217; test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test; test name: scan; result unstructured data: test result:did not detect any issues
Liste des symptômes
condition aggravated musculoskeletal chest pain interchange of vaccine products scan sars-cov-2 test off label use
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na